Jurriën M. ten Berg

Jurriën M. ten Berg publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jurriën M. ten Berg sits on this spectrum.

Jurriën M. ten Berg D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jurriën M. ten Berg sits on this spectrum.

Best Publications

• 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

  Marco Valgimigli;Héctor Bueno;Robert A Byrne;Jean-Philippe Collet

  3116
  Citations

• Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

  Willem J. M. Dewilde;Tom Oirbans;Freek W. A. Verheugt;Johannes C. Kelder

  2114
  Citations

• Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

  Christopher P. Cannon;Deepak L. Bhatt;Jonas Oldgren;Gregory Y.H. Lip

  1257
  Citations

• Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation

  Nicoline J. Breet;Jochem W. van Werkum;Heleen J. Bouman;Johannes C. Kelder

  1185
  Citations

• Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

  Udaya S. Tantry;Laurent Bonello;Daniel Aradi;Matthew J. Price

  931
  Citations

• Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.

  Jochem W. van Werkum;Antonius A. Heestermans;A. Carla Zomer;Johannes C. Kelder

  784
  Citations

• Abciximab in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention After Clopidogrel Pretreatment: The ISAR-REACT 2 Randomized Trial

  Adnan Kastrati;Julinda Mehilli;Franz-Josef Neumann;Franz Dotzer

  779
  Citations

• Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes

  Gilles Montalescot;Leonardo Bolognese;Dariusz Dudek;Patrick Goldstein

  713
  Citations

• Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial

  Arnoud Wj van't Hof;Jurriën ten Berg;Ton Heestermans;Thorsten Dill

  641
  Citations

• Paraoxonase-1 is a major determinant of clopidogrel efficacy

  Heleen J Bouman;Edgar Schömig;Jochem W van Werkum;Janna Velder

  620
  Citations

• A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.

  Adnan Kastrati;Julinda Mehilli;Helmut Schühlen;Josef Dirschinger

  607
  Citations

• Bivalirudin Started during Emergency Transport for Primary PCI

  Philippe Gabriel Steg;Christian W. Hamm;Peter Clemmensen;Frédéric Lapostolle

  573
  Citations

• Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention

  Dirk Sibbing;Daniel Aradi;Dimitrios Alexopoulos;Jurrien ten Berg

  516
  Citations

• Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data.

  Somjot S. Brar;Jurrien ten Berg;Rossella Marcucci;Matthew J. Price

  507
  Citations

• Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

  Gregory Y H Lip;Stephan Windecker;Kurt Huber;Paulus Kirchhof

  484
  Citations

• Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention

  Dániel Aradi;Ajay Kirtane;Laurent Bonello;Paul A. Gurbel

  407
  Citations

• ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.

  Stefanie Schulz-Schüpke;Robert A Byrne;Jurrien M Ten Berg;Franz-Josef Neumann

  404
  Citations

• Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis

  Tim Bauer;Heleen J Bouman;Jochem W van Werkum;Neville F Ford

  348
  Citations

• Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial

  Alexander Hirsch;Robin Nijveldt;Pieter A. van der Vleuten;Jan G.P. Tijssen

  326
  Citations

• Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation

  Jorn Brouwer;Vincent J Nijenhuis;Ronak Delewi;Renicus S Hermanides

  311
  Citations